12 results
Liver Mass Differential Diagnosis
Solid:
 • Benign: Hepatic Hemangioma, Focal nodular hyperplasia, Hepatocellular adenoma, Regenerative nodules
 •
Liver Mass Differential ... Diagnosis Solid: • Benign ... : Hepatic Hemangioma ... #Differential # ... Diagnosis #hepatology
Hepatic Masses on CT - Differential Diagnosis by CT Findings

Masses: Hemangioma, Adenoma, FNH, HCC, Fibrolamellar HCC,
Hepatic Masses on ... CT - Differential ... #differential # ... diagnosis #liver #hepatology ... #radiology #mass
Liver Mass - Differential Diagnosis Algorithm
Benign Cystic 
 • Cyst
 • Polycystic Liver Disease
 • Caroli's
Liver Mass - Differential ... Diagnosis Algorithm Benign ... Cystadenocarcinoma Benign ... Breast) #Liver #Mass ... #Hepatology #Differential
Hepatic Masses on MRI - Differential Diagnosis by MRI Findings

Masses: Hemangioma, Adenoma, FNH, HCC, Fibrolamellar HCC,
Hepatic Masses on ... MRI - Differential ... #Masses #MRI #differential ... diagnosis #liver #hepatology ... #radiology #mass
Liver Mass - Differential Diagnosis Algorithm
Cystic:
 • Benign 
     - Simple: Simple
Liver Mass - Differential ... Algorithm Cystic: • Benign ... kwburak #Liver #Mass ... #Differential # ... Algorithm #Causes #Hepatology
Portal venous gas on hepatic ultrasound: A concerning finding in the critically ill patient that should
venous gas on hepatic ... reflection on the differential ... The images (CT | ... can occur with benign ... venousgas #ultrasound #hepatology
Appearance of Liver Lesions on Various Imaging Modalities
 • Computed Tomography (CT) - Arterial Phase, Portal
Computed Tomography (CT ... Liver #Lesions #Hepatic ... Ultrasound #Contrast #CT ... POCUS #radiology #differential ... table #appearance #hepatology
Appearance of Liver Lesions on Computed Tomography (CT) - Arterial Phase, Portal Venous Phase and Delayed
Computed Tomography (CT ... Liver #Lesions #Hepatic ... ComputedTomography #CT ... #radiology #differential ... table #appearance #hepatology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
evidence base being ... molecular weight heparin ... ; BMI = body mass ... Anticoagulation #Management #Hematology
Nutrition in Cirrhosis: Dos and Don’ts
Screening:
 • Patients at risk for RFH-Nutritional Prioritizing Tool
 • Low
Assessment) • Muscle mass ... Anthropometry, CT ... maintaining muscle mass ... prevent or treat hepatic ... diet #management #hepatology